As GLP-1 demand continues to rise, manufacturers that have already begun repositioning will have a head start in the coming years
You may be eligible to file a Depo Provera Lawsuit if you used Depo-Provera and were diagnosed with a brain tumor
One meta-analysis and systemic review of 26 trials published in April 2025 in JAMA Neurology suggested that they could help lower dementia risk
Most of it resolves as the dose titrates
Over time, obese patients lose roughly 12% of their body weight on Wegovy (semaglutide) and about 18% on Zepbound (tirzepatide, which targets GLP-1 and another gut hormone, GIP.) Diana Thiara, MD, medical director of the UCSF Weight Management Program, says the results can be amazing and life-changing for people with obesity, a condition linked to a host of health risks
Ozempic is approved to treat type 2 diabetes